225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study M Sathekge, F Bruchertseifer, O Knoesen, F Reyneke, I Lawal, T Lengana, ... European journal of nuclear medicine and molecular imaging 46, 129-138, 2019 | 299 | 2019 |
Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study FL Giesel, L Will, I Lawal, T Lengana, C Kratochwil, M Vorster, O Neels, ... Journal of Nuclear Medicine 59 (7), 1076-1080, 2018 | 176 | 2018 |
Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 61 (1), 62-69, 2020 | 157 | 2020 |
68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli? T Lengana, IO Lawal, TG Boshomane, GO Popoola, KMG Mokoala, ... Clinical genitourinary cancer 16 (5), 392-401, 2018 | 109 | 2018 |
F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection I Lawal, M Sathekge British Medical Bulletin 120 (1), 55-74, 2016 | 62 | 2016 |
Diagnostic sensitivity of Tc‐99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga‐68 PSMA PET/CT IO Lawal, AO Ankrah, NP Mokgoro, M Vorster, A Maes, MM Sathekge The Prostate 77 (11), 1205-1212, 2017 | 58 | 2017 |
Metabolic imaging of infection I Lawal, JR Zeevaart, T Ebenhan, A Ankrah, M Vorster, HG Kruger, ... Journal of Nuclear Medicine 58 (11), 1727-1732, 2017 | 53 | 2017 |
Monitoring response to therapy MM Sathekge, AO Ankrah, I Lawal, M Vorster Seminars in nuclear medicine 48 (2), 166-181, 2018 | 46 | 2018 |
Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617 MM Sathekge, F Bruchertseifer, IO Lawal, M Vorster, O Knoesen, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1756-1757, 2019 | 37 | 2019 |
Global experience with PSMA-based alpha therapy in prostate cancer MM Sathekge, F Bruchertseifer, M Vorster, A Morgenstern, IO Lawal European Journal of Nuclear Medicine and Molecular Imaging 49 (1), 30-46, 2021 | 33 | 2021 |
68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans M Sathekge, T Lengana, A Maes, M Vorster, JR Zeevaart, I Lawal, ... European Journal of Nuclear Medicine and Molecular Imaging 45, 226-234, 2018 | 33 | 2018 |
Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT M Sathekge, O Garcia-Perez, D Paez, N El-Haj, T Kain-Godoy, I Lawal, ... Annals of Nuclear Medicine 32, 54-59, 2018 | 33 | 2018 |
mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting: response to treatment and survival analysis M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 63 (10), 1496-1502, 2022 | 30 | 2022 |
COVID-19 is a multi-organ aggressor: epigenetic and clinical marks MM Kgatle, IO Lawal, G Mashabela, TMG Boshomane, PC Koatale, ... Frontiers in Immunology 12, 752380, 2021 | 29 | 2021 |
Arterial inflammation in young patients with human immunodeficiency virus infection: a cross-sectional study using F-18 FDG PET/CT IO Lawal, AO Ankrah, GO Popoola, T Lengana, MM Sathekge Journal of Nuclear Cardiology 26 (4), 1258-1265, 2019 | 28 | 2019 |
A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for … IO Lawal, KMG Mokoala, J Mahapane, J Kleyhans, M Meckel, M Vorster, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 134-142, 2021 | 26 | 2021 |
18F-FDG PET/CT as a noninvasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis IO Lawal, BP Fourie, M Mathebula, I Moagi, T Lengana, N Moeketsi, ... Journal of Nuclear Medicine 61 (3), 412-417, 2020 | 26 | 2020 |
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer IO Lawal, F Bruchertseifer, M Vorster, A Morgenstern, MM Sathekge Current Opinion in Urology 30 (1), 98-105, 2020 | 25 | 2020 |
The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma IO Lawal, NE Nyakale, LM Harry, MR Modiselle, AO Ankrah, AP Msomi, ... European Journal of Nuclear Medicine and Molecular Imaging 44, 2025-2033, 2017 | 25 | 2017 |
PSMA theranostics: science and practice K Mokoala, I Lawal, T Lengana, M Kgatle, FL Giesel, M Vorster, ... Cancers 13 (15), 3904, 2021 | 24 | 2021 |